SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

Atlantic Equities Upgrades AbbVie to Overweight, Announces $115 Price Target

Atlantic Equities analyst Steve Chesney upgrades AbbVie (NYSE:ABBV) from Neutral to Overweight and announces $115 price target.

Benzinga · -
Atlantic Equities analyst Steve Chesney upgrades AbbVie (NYSE: ABBV) from Neutral to Overweight and announces $115 price target.